Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

  1. Home
  2. Professionals
  3. Stephanie W. Bignon
  1. Back
Stephanie Bignon
Stephanie W. Bignon
Associate
Washington +1 202 662 5393 sbignon@cov.com Download V-card
View Less

Stephanie Bignon is a corporate associate who represents public and private companies and their boards on a variety of issues, including disclosure and securities compliance, corporate governance, and capital markets and financing transactions. Ms. Bignon has experience representing companies in a range of industries, including life sciences, technology, manufacturing, and financial services. Prior to joining Covington, Ms. Bignon worked as a public company auditor and senior external financial reporting analyst at Delta Air Lines.

Transactional 

  • Uber Technologies, Inc. in connection with its initial public offering.
  • Eli Lilly and Company in more than $10 billion of various debt offerings and a €2.1 billion Eurobond offering.
  • Avnet, Inc. in $850 million of registered debt offerings, its $1.25 million senior unsecured credit facility and its $500 million securitization facility.
  • Insmed Incorporated in $652.5 million of registered common stock offerings.
  • A public consulting company in connection with its acquisition by a private equity fund.
  • Clinical-stage private biotechnology company in multiple rounds of preferred stock financing.
  • Underwriters in connection with the initial public offering of a bank holding company.
  • HealthSouth Corporation in $1 billion of various debt offerings.
  • Salix Pharmaceuticals, Ltd. in a $750.0 million high yield bond offering.
  • National Football League in connection with various league and stadium financings and ownership transactions, including its G-4 stadium funding program.

Advisory

  • Various public companies on Exchange Act reporting, including periodic reports and proxy statements, shareholder proposals, Section 16 reporting, responses to SEC staff comment letters, and other securities compliance matters.
  • Various public and private companies in corporate governance matters, including executive compensation programs, disclosure controls and procedures, internal control over financial reporting, compliance program design and board committee charters.
View More View Less

Pro Bono

  • Non-profit membership association in connection with its reincorporation and qualification for tax-exempt status.

Previous Experience

  • Senior Analyst in External Financial Reporting at Delta Air Lines, Inc. (2007-2008).
  • Senior Assurance Associate (2007) and Assurance Associate (2005-2007) at Grant Thornton LLP.

Practices

University of Maryland School of Law, J.D., 2011

  • summa cum laude
  • Maryland Law Review, Executive Notes and Comments Editor
  • Recipient of the Elizabeth Maxwell Carroll Chesnut and William Strobel Thomas graduation awards

Georgia Institute of Technology, B.S., 2005

  • Highest Honors
  • President’s Undergraduate Research Award Recipient
  • Hon. Deborah K. Chasanow, U.S. District Court, District of Maryland, 2011 - 2012
  • District of Columbia
  • Georgia
  • French